Regional Fish Institute Ltd. in Japan is now accepting orders on a crowdfunding site for genetically manipulated farmed red sea bream that boasts 1.2 times thicker flesh than ordinary farmed ones.
Sales are initially restricted to 190 customers with deliveries expected to start in October. The production process is explained in detail with each purchase.
Kyoto University and Kindai University developed the fleshier fish variant by rendering a gene called myostatin that controls muscle growth.
The Regional Fish Institute, a biotech enterprise affiliated with Kyoto University, registered the commercialization of its “genome-edited food” with the government on Sept. 17.
On the same day, the health ministry declared that no safety examinations were required.
Genome editing, which aims to destroy or introduce particular genes, is also applied for increasing harvest yields in rice and other plant varieties.
As no foreign genes from other species were introduced into genome-processed items, as with genetic recombination, no safety checks were necessary.
This method is essentially the same as traditional selective breeding methods to create improved varieties.
The institute's sea bream is the first genome-edited animal product to be marketed in Japan.


SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Gold Prices Fall as US-Iran Conflict, Rising Oil Prices Fuel Fed Rate Concerns
Trump, Canada Reach Gordie Howe Bridge Deal Ahead of July 27 Opening
SpaceX Delays Starship V3 Launch Ahead of Potential Record IPO
Dollar Eases as Middle East Conflict, Fed Outlook and Japan Pension Policy Drive FX Markets
NASA's Artemis II Mission: First Crewed Lunar Journey Since Apollo
Fed Reaffirms 2% Inflation Goal, Vows Forceful Action to Anchor Price Expectations
EU Weighs New Trade Restrictions on Israeli West Bank Settlements
Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028
NASA Artemis II: First Crewed Moon Mission Since Apollo Takes Four Astronauts on 10-Day Lunar Journey
Australian Business Conditions Hold Steady as Easing Cost Pressures Face New Oil Price Risks
Goldman Sees Foreign Investors Driving India Stock Market Recovery
South Korea’s KOSPI Triggers Trading Curb as AI Chip Stock Selloff Deepens
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



